Palpable Breast Mass — Age-Based Imaging & Biopsy Pathway
Source: ACR Appropriateness Criteria: Palpable Breast Masses, 2022 Update, Journal of the American College of Radiology
Guideline: Strong
Guideline: Conditional
Guideline: Not recommended
ClinicoQ pathway suggestion (not from the cited guideline)
Diagnosis
Diagnostic criteria
A new palpable breast mass requires a thorough clinical breast exam plus imaging in almost all cases, since exam findings alone cannot reliably distinguish benign from malignant masses. Imaging choice is age-stratified (see workup). If imaging is BI-RADS 4/5 (suspicious/highly suggestive of malignancy), image-guided core biopsy is indicated; if benign/probably benign (BI-RADS 1-3), further imaging is generally not needed unless the clinical exam remains concerning.
⚠ Alarm features (investigate before diagnosing)
- Skin changes (dimpling, peau d'orange, ulceration)
- Nipple retraction or bloody nipple discharge
- Axillary lymphadenopathy
- Rapidly enlarging or fixed, hard, irregular mass on exam — clinical suspicion can warrant biopsy even with reassuring imaging
Initial workup
| Test | When to order |
|---|---|
| Ultrasound (targeted breast US) | First-line/primary imaging for women under 30; combined with mammography/tomosynthesis for ages 30-39; used as an adjunct for women 40+ if mammogram is negative but suspicion remains, or immediately if mammography is suspicious. |
| Diagnostic mammography / tomosynthesis | Initial imaging of choice for women 40 and older; used alongside ultrasound for ages 30-39. |
| Image-guided core biopsy | When imaging shows a suspicious finding (BI-RADS 4/5); preferred over FNA for sensitivity/specificity, though some practices use FNA as an initial step. |
Decision Points
❓ What is the patient's age?
❓ What is the BI-RADS assessment on imaging?
Treatment
Ultrasound first (age <30)
1
Targeted breast ultrasound
Strong (Guideline recommendation)
- Dose
- — imaging study
- Duration
- Initial workup step
- Evidence level
- Moderate
- Avoid if
- —
- If no response ClinicoQ pathway
- If suspicious findings, proceed to biopsy; note there is no evidence to support image-guided FNA as an initial workup step in women under 30 with a probably benign ultrasound
Ultrasound + mammography/tomosynthesis (age 30-39)
1
Ultrasound and diagnostic mammography/tomosynthesis
Strong (Guideline recommendation) — both usually appropriate in this age group
- Dose
- — imaging studies
- Duration
- Initial workup step
- Evidence level
- Moderate
- Avoid if
- —
- If no response ClinicoQ pathway
- Proceed to biopsy if suspicious findings on either modality
Diagnostic mammography/tomosynthesis first (age ≥40)
1
Diagnostic mammography or tomosynthesis
Strong (Guideline recommendation)
- Dose
- — imaging study
- Duration
- Initial workup step
- Evidence level
- Moderate
- Avoid if
- —
- If no response ClinicoQ pathway
- Add ultrasound if the patient had a negative mammogram within the past 6 months, or immediately if mammography findings are suspicious
Image-guided core biopsy
1
Ultrasound-guided (or mammography-guided) core needle biopsy
Strong (Guideline recommendation) — core biopsy generally preferred over FNA for accuracy
- Dose
- — procedure
- Duration
- After suspicious imaging finding, unless contraindicated
- Evidence level
- Moderate
- Avoid if
- Comorbidities that would contraindicate biopsy (rare)
- If no response ClinicoQ pathway
- Refer to breast surgery/oncology based on histopathology results
No further imaging; clinical follow-up
1
Routine clinical follow-up; no further imaging needed
Strong (Guideline recommendation)
- Dose
- —
- Duration
- Per routine screening schedule, unless the clinical exam remains concerning
- Evidence level
- Moderate
- Avoid if
- Physical exam findings remain concerning despite benign imaging — discuss biopsy based on clinical suspicion
✕ Treatments the guideline advises against
Breast MRI, PEM, or molecular breast imaging as routine initial evaluation of a palpable mass: Guideline states there is little role for these advanced technologies in the initial evaluation of a palpable mass.
Image-guided core biopsy as the very first workup step in women under 30: No evidence supports this as an initial step; imaging (ultrasound) should come first.
⚠️ This is an educational summary of current international clinical practice guidelines and does not replace individualized clinical judgment. Final treatment decisions remain the responsibility of the treating physician.